Perchloroethylene Reagent Supply

The contract pertains to the supply of high-purity perchloroethylene (PCE) reagent, a critical raw material used to fill capillaries in diagnostic chips that are integral to the final medical device. This reagent must meet strict purity standards to ensure the reliability and accuracy of diagnostic outcomes, making it a vital component in the production process. The subcontract is issued under the Department of Defense’s Medical Supply Chain MD SURG FSF, with performance required at APO, ZIP 09094-3219, indicating a deployment or military medical support context. The material’s application in life-critical diagnostics underscores the necessity for consistent quality, traceability, and on-time delivery throughout the supply chain. The solicitation was posted on July 16, 2026, with a response deadline of July 22, 2026, indicating a tightly constrained procurement timeline. The NAICS code 325193 classifies this as a specialty chemical manufacturing activity, aligning with the production of reagents for medical and diagnostic use. As a subcontract, the award is likely part of a larger supply chain managed by a prime contractor supporting defense medical systems. The absence of set-aside information suggests eligibility is open to all qualified suppliers, but technical capability and compliance with purity and regulatory requirements will be decisive. The procurement process is managed through the DLA DIBBS platform, and successful bidders must demonstrate proven experience in supplying high-purity chemicals for medical diagnostics under stringent quality controls.